Research location
Conroe
Texas, United States
Advertisement
Research activity in Conroe
Texas, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 80 trials and 81 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Conroe
80 linked trials · page 2 of 2Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung CancerNCT03391869 · 2017-12-29 · 1 site observation
ACTIVE_NOT_RECRUITING
Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung CancerNCT03110978 · 2017-06-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast CancerNCT03077841 · 2017-03-06 · 1 site observation
SUSPENDED
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast CancerNCT02954874 · 2017-01-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation TherapyNCT02927249 · 2017-01-06 · 1 site observation
TERMINATED
Breast Cancer WEight Loss Study (BWEL Study)NCT02750826 · 2016-09-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot InitiativeNCT02276443 · 2015-11-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesNCT02419495 · 2015-06-26 · 1 site observation
TERMINATED
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)NCT02201992 · 2015-03-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)NCT02193282 · 2015-02-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738 · 2014-09-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung CancerNCT02186847 · 2014-08-01 · 1 site observation
COMPLETED
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyNCT01901094 · 2014-02-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerNCT01272037 · 2011-02-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast CancerNCT01266642 · 2011-02-08 · 1 site observation
ACTIVE_NOT_RECRUITING
Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected PatientsNCT00782301 · 2009-03-01 · 1 site observation
WITHDRAWN
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and EtoposideNCT00632853 · 2008-03-01 · 1 site observation
COMPLETED
Study of Rivoglitazone in Type 2 Diabetes MellitusNCT00484198 · 2007-04-23 · 1 site observation
COMPLETED
Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic PatientsNCT00396214 · 2007-04-01 · 1 site observation
TERMINATED
Switch Study of Existing Atypical Antipsychotics to BifeprunoxNCT00347425 · 2006-12-01 · 1 site observation
COMPLETED
Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes MellitusNCT00395512 · 2006-11-01 · 1 site observation
COMPLETED
Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 DiabetesNCT00104182 · 2005-02-01 · 1 site observation
COMPLETED
A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.NCT00111189 · 2005-02-01 · 1 site observation
COMPLETED
Placebo and Active Controlled Study of Rivoglitazone in Type 2 DiabetesNCT00143520 · 2004-12-01 · 1 site observation
COMPLETED
Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective DisorderNCT00090012 · 2004-07-01 · 1 site observation
COMPLETED
Major Depressive Disorder Study In AdultsNCT00049972 · 2002-09-01 · 1 site observation
COMPLETED
CAFE Comparison of Atypicals in First Episode of PsychosisNCT00034892 · 2002-03-01 · 1 site observation
COMPLETED
CATIE- Schizophrenia TrialNCT00014001 · 2000-12-01 · 1 site observation
COMPLETED
Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and DyslipidemiaNCT00331487 · 2000-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.